These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 7989292)

  • 1. Functional imaging in dementia: an overview.
    Jagust WJ
    J Clin Psychiatry; 1994 Nov; 55 Suppl():5-11. PubMed ID: 7989292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determinations of cerebral glucose utilization in dementia using positron emission tomography.
    Kuhl DE; Metter EJ; Riege WH; Hawkins RA
    Dan Med Bull; 1985 Feb; 32 Suppl 1():51-5. PubMed ID: 3872772
    [No Abstract]   [Full Text] [Related]  

  • 3. Positron emission tomography and single-photon emission computed tomography brain imaging in the evaluation of dementia.
    Van Heertum RL; Tikofsky RS
    Semin Nucl Med; 2003 Jan; 33(1):77-85. PubMed ID: 12605358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical correlates of PET- and SPECT-identified defects in dementia.
    Mayberg HS
    J Clin Psychiatry; 1994 Nov; 55 Suppl():12-21. PubMed ID: 7989290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Positron emission tomography in dementia.
    Friedland RP
    Semin Neurol; 1989 Dec; 9(4):338-44. PubMed ID: 2701778
    [No Abstract]   [Full Text] [Related]  

  • 6. Positron emission tomography as an imaging tool in psychiatric disorders.
    Heiss WD; Pawlik G; Herholz K; Szelies B; Wienhard K
    Psychiatry Res; 1989 Sep; 29(3):351-2. PubMed ID: 2532752
    [No Abstract]   [Full Text] [Related]  

  • 7. Neuroimaging for diagnosis of dementia.
    Small GW; Leiter F
    J Clin Psychiatry; 1998; 59 Suppl 11():4-7. PubMed ID: 9731543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 18F-2-deoxy-2-fluoro-D-glucose as a tracer in the positron emission tomographic study of senile dementia.
    Farkas T; Ferris SH; Wolf AP; De Leon MJ; Christman DR; Reisberg B; Alavi A; Fowler JS; George AE; Reivich M
    Am J Psychiatry; 1982 Mar; 139(3):352-3. PubMed ID: 6977276
    [No Abstract]   [Full Text] [Related]  

  • 9. A comparison of FDG PET and IQNB SPECT in normal subjects and in patients with dementia.
    Weinberger DR; Jones D; Reba RC; Mann U; Coppola R; Gibson R; Gorey J; Braun A; Chase TN
    J Neuropsychiatry Clin Neurosci; 1992; 4(3):239-48. PubMed ID: 1498576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional MR in the evaluation of dementia: correlation of abnormal dynamic cerebral blood volume measurements with changes in cerebral metabolism on positron emission tomography with fludeoxyglucose F 18.
    González RG; Fischman AJ; Guimaraes AR; Carr CA; Stern CE; Halpern EF; Growdon JH; Rosen BR
    AJNR Am J Neuroradiol; 1995 Oct; 16(9):1763-70. PubMed ID: 8693972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional brain imaging in the dementias: role in early detection, differential diagnosis, and longitudinal studies.
    Devous MD
    Eur J Nucl Med Mol Imaging; 2002 Dec; 29(12):1685-96. PubMed ID: 12458405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating dementia using PET: how do we put into clinical perspective what we know to date?
    Silverman DH; Phelps ME
    J Nucl Med; 2000 Nov; 41(11):1929-32. PubMed ID: 11079506
    [No Abstract]   [Full Text] [Related]  

  • 13. Characteristics of cerebral glucose utilization in dementia.
    Matsuzawa T; Matsui H; Meguro K; Ueda M; Yamada K; Yamaguchi T; Itoh M; Hatazawa J; Kinomura S
    Sci Rep Res Inst Tohoku Univ Med; 1990 Dec; 37(1-4):11-21. PubMed ID: 2103655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Positron emission tomography in dementia.
    Santens P; Petit H
    Acta Neurol Belg; 1997 Sep; 97(3):192-5. PubMed ID: 9345592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regional cerebral metabolic alterations in dementia of the Alzheimer type: positron emission tomography with [18F]fluorodeoxyglucose.
    Friedland RP; Budinger TF; Ganz E; Yano Y; Mathis CA; Koss B; Ober BA; Huesman RH; Derenzo SE
    J Comput Assist Tomogr; 1983 Aug; 7(4):590-8. PubMed ID: 6602819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MRI, CT, SPECT, PET: their use in diagnosing dementia.
    Jagust WJ; Eberling JL
    Geriatrics; 1991 Feb; 46(2):28-35. PubMed ID: 1991619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain glucose metabolism in Parkinson's disease.
    Metter EJ; Kuhl DE; Riege WH
    Adv Neurol; 1990; 53():135-9. PubMed ID: 2239454
    [No Abstract]   [Full Text] [Related]  

  • 18. Functional brain imaging in late-life depression and dementia.
    Kumar A
    J Clin Psychiatry; 1993 Nov; 54 Suppl():21-5. PubMed ID: 8270594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Single-photon emission-computed tomography in the differential diagnosis of dementia].
    Deisenhammer E; Reisecker F; Leblhuber F; Höll K; Markut H; Trenkler J; Schneider I
    Dtsch Med Wochenschr; 1989 Oct; 114(43):1639-44. PubMed ID: 2530079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of functional imaging in Parkinsonism and dementia.
    Burn DJ; O'Brien JT
    Mov Disord; 2003 Sep; 18 Suppl 6():S88-95. PubMed ID: 14502661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.